TCG Crossover
Edit

TCG Crossover

https://tcgcrossover.com
Last activity: 18.04.2024
Invests in categories: BioTechPlatformDrugTechnologyMedTechResearchDevelopmentLifeBuildingEngineering
TCG Crossover is a science-driven investment firm dedicated to advancing disruptive medicines.
News
48
Portfolio
19
Mentions
2
Employees: 11-50
Email

Portfolio 19

DateNameWebsiteTotal RaisedLocation
09.02.2024CG Oncolog...cgoncology...$547MUnited Sta...
13.08.2023ADARx Phar...adarx.com$321MCanada
07.08.2023Gracell Bi...gracellbio...$250MChina, Jia...
25.07.2023Tourmaline...tourmaline...$75MUnited Sta...
25.07.2023Versanis B...versanisbi...$70MUnited Sta...
13.06.2023Carmot The...carmot.us$150MUnited Sta...
13.06.2023Alkeus Pha...alkeusphar...$150MUnited Sta...
-Upstream B...upstreambi...$400MUnited Sta...
-Artiosartiosphar...$239M-
-Plexiumplexium.co...$165MUnited Sta...
Show more

News 48

DateTitleDescription
08.02.2024Announces $120 Million Private Placement Financing-
05.02.2024Announces $127.5 Million Private Placement Financing-
05.02.2024Announces Oversubscribed $120 Million Private Placement-
30.01.2024Announces Pricing Of $125 Million Underwritten Offering-
24.01.2024Announces Pricing of Upsized Initial Public Offering-
19.01.2024Announces Pricing of $240 Million Underwritten Offering of C...-
04.01.2024TCG Crossover (“TCGX”) Announces Oversubscribed $1B TCGX Fun...-
26.12.2023Adds Premier Radiopharmaceutical Platform with Acquisition o...-
26.12.2023To be acquired by AstraZeneca, furthering cell therapy ambit...-
12.12.2023Icosavax, Inc. Announces Agreement to be Acquired by AstraZe...-
Show more

Mentions in press and media 2

DateTitleDescriptionSource
05.01.2024TCG Crossover Closes $1B TCGX Fund IITCG Crossover, a Palo Alto, CA- and NYC-based life sciences-focused investment firm with a flexible ...finsmes.co...
04.01.2024TCG Crossover (“TCGX”) Announces Oversubscribed $1B TCGX Fun...-tcgcrossov...

Reviews 0

Sign up to leave a review

Sign up Log In